PHILADELPHIA – The question of trade with China is front and center in the Trump administration's policy agenda, and a panel discussion at this year's MedTech Conference concluded that Beijing does indeed abuse its trade privileges. Most of the levers available to Washington may have a middling effect at best on China's high baseline tariffs and rampant intellectual property theft, however, leaving device makers doing business with this Asian colossus with a massive overhang of uncertainty. Read More
